Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 14

Learn how the quantitative BTA TRAK urine test relates to bladder cancer, what elevated values may mean, why false positives occur, and how it fits into recurrence monitoring.

Bladder Tumor Antigen TRAK Test: Bladder Cancer Monitoring, Recurrence Risk, and...

Learn how Cxbladder urine testing uses gene expression and DNA markers, what Triage, Triage Plus, and Monitor scores mean, and how results fit into bladder cancer evaluation.

Cxbladder Test: Bladder Cancer Gene Expression, Risk Score, and Urine Marker...

Understand the ExoDx Prostate urine test, including exosome RNA markers, the 15.6 risk cutoff, accuracy, biopsy decisions, MRI use, and result meaning.

ExoDx Prostate Test: Urine Exosome Biomarkers, Prostate Cancer Risk, and Result...

Learn how the ImmunoCyt/uCyt+ urine test uses fluorescent antibodies to support bladder cancer detection, cytology follow-up, result interpretation, and surveillance decisions.

ImmunoCyt Test: Bladder Cancer Urine Marker, Fluorescent Antibodies, and Cytology Follow-Up

Explore KIM-1, aquaporin-1, and perilipin-2 urine biomarker research for kidney cancer, including RCC evidence, limitations, diagnostic accuracy, and current clinical use.

Kidney Cancer Urine Biomarker Panel: KIM-1, Aquaporin-1, Perilipin-2, and Diagnostic Research

Understand the NMP22 urine test for bladder cancer, including the 10 U/mL cutoff, high results, false positives, BladderChek accuracy, and recurrence monitoring.

NMP22 Urine Test: Bladder Cancer Marker, High Levels, and Recurrence Monitoring

Understand the PCA3 urine test, including post-DRE collection, the historical score cutoff of 25, repeat-biopsy use, PSA follow-up, limitations, and current availability.

PCA3 Urine Test: Prostate Cancer Risk, PSA Follow-Up, Repeat Biopsy, and...

Understand what the SelectMDx urine test measures, how HOXC6 and DLX1 gene markers affect prostate cancer risk estimates, and what positive or negative results may mean.

SelectMDx Urine Test: Prostate Cancer Risk, Gene Markers, and Result Meaning

Learn what a urine BTA test detects, how BTA stat and BTA TRAK differ, what a positive result can mean, and why infection, blood, or stones can cause false positives.

Urine BTA Test: Bladder Tumor Antigen, Positive Result, and Bladder Cancer...

Learn what a urine catecholamines test measures, why epinephrine, norepinephrine, or dopamine may be high, how tumors affect results, and why metanephrines are often preferred.

Urine Catecholamines Test: Neuroendocrine Tumors, Adrenal Tumors, High Levels, and Meaning

Learn how urine cytology detects cancer cells, what atypical urothelial cells mean, why negative cytology can miss low-grade bladder cancer, and what follow-up may be needed.

Urine Cytology Test: Cancer Cells, Bladder Cancer, Atypical Cells, and Result...

Learn how urine free kappa and lambda light chains relate to Bence Jones protein, multiple myeloma, kidney injury, and why serum FLC and immunofixation often guide interpretation.

Urine Free Light Chains Test: Multiple Myeloma, Bence Jones Protein, and...

Learn what urine immunofixation detects, how monoclonal kappa or lambda light chains relate to Bence Jones protein and myeloma, and what positive or negative results mean.

Urine Immunofixation Test: Monoclonal Protein, Light Chain Type, Myeloma, and Result...

Learn how a 24-hour urine metanephrines test detects pheochromocytoma and paraganglioma, what high or borderline results mean, and how collection and medications affect accuracy.

Urine Metanephrines Test: Pheochromocytoma, Paraganglioma, High Levels, and Adrenal Tumors

Understand urine tumor marker panels for bladder and kidney cancer, including NMP22, BTA, UroVysion, molecular tests, KIM-1, result meaning, and limitations.

Urine Tumor Marker Test Panel: Bladder Cancer Markers, Kidney Cancer Markers,...

Learn what the UroVysion FISH urine test measures, including chromosomes 3, 7, 17 and 9p21, what positive or negative results mean, and how cytology follow-up works.

UroVysion FISH Test: Bladder Cancer Chromosome Markers, Positive Result, and Cytology...

1...131415...137 Page 14 of 137